19-Methyl Analogs of Vitamin D3: Synthesis and Structure Elucidation by 1HNMR

• Autorzy: Szoka P. , Siciński R.
• Konferencja: 1st Symp. on NMR in Chemistry, Biology and Medicine; 8-10 Semptember, Warsaw, Poland. Issue dedicated to honour Prof. Witanowski
• Języki publikacji: EN

Abstrakty

EN

Synthesis of three isomeric 19-methylated vitamin D3 derivatives is described. Two different synthetic paths were used, both involving 3,5-cyclovitamin D precursors easily obtainable from commercial vitamin D3. The crucial step of the first route consisted of an acid-catalyzed cycloreversion of isomeric 19-methyl-3,5-cyclovitamin D3 compounds, whereas in the other it involved a Wittig reaction of 10-oxo-19-norvitamin analogs. Neither iodine-catalyzed nor thermal isomerization of the 5Z,10E-isomer provided detectable quantities of the fourth possible isomeric vitamin with a 5Z,10Z-configuration. Structures, stereochemistries and A-ring conformations of the final 19-methyl vitamin D3 analogs were tentatively established on the basis of their 500-MHz 1H NMR spectra and conformational analysis. Application of 1H NOE difference spectroscopy andmolecular modeling studies allowed for the assignment of preferred solution conformations of the 3,5-cyclovitamin D3 intermediates.

Słowa kluczowe

EN

vitamins D; 3,5-cyclovitaminsD; 5,6-trans-vitaminsD; cycloreversion process

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Polish Journal of Chemistry
• Rocznik: 2006
• Tom: Vol. 80, nr 7
• Strony: 1155--1168
• Opis fizyczny: Bibliogr. 21 poz., rys.

Twórcy

autor

Szoka P.

autor

Siciński R.

• Department of Chemistry, University of Warsaw, ul. Pasteura 1, 02-093 Warsaw, Poland

Bibliografia

• 1. Hanewald K.H., Rappoldt M.P. and Roborgh J.R., Rec. Trav. Chim. Pays-Bas., 80, 1003 (1961).
• 2. Okamura W.H., Elmagar H. Y., Ruther M. and Dobreff S., J. Org. Chem., 58, 600 (1993).
• 3. Norman A.W., Vitamin D, the Calcium Homeostatic Steroid Hormone, Ed. Academic Press, New York 1979, p. 37.
• 4. Dauben W.G., Kohler, B. and Roesle A., J. Org. Chem., 50, 2007 (1985).
• 5. Sheves M. and Mazur V, J. Chem. Soc., Chem. Commun.,21 (1977).
• 6. Sialom B. and Mazur V, J. Org. Chem., 45, 2201 (1980).
• 7. Moriarty R.M. and Paaren H.E., J. Org. Chem., 46, 970 (1981).
• 8. Siciński R.R., Acta Chim. Hung., 129, 191 (1992).
• 9. Yamada S., Suzuki T. and Takayama H., Tetrahedron Lett., 22, 3085 (1981).
• 10. Shimizu M., Iwasaki Y, Ohno A. and Yamada S., Chem. Pharm. Bull, 48, 1484 (2000).
• 11. Eguchi T., Kaninuma K. and Ikekawa N., Bioorg. Chem., 19, 327 (1991).
• 12. Paaren H.E., DeLuca H.F. and Schnoes H.K., J. Org. Chem., 45, 3253 (1980).
• 13. Addo J.K. and Ray R., Steroids, 63, 218 (1998).
• 14. Sheves M. and Mazur Y, J. Am. Chem. Soc., 97, 6249 (1975).
• 15. Initial geometry of each cyclovitamin was obtained by steric energy minimization performed by HyperChem program and such structure was used for the generation of other conformers with the aid of Conformational Search module. In each examined compound the bonds C(5)-C(6), C(6)-O and C(6)-C(7) were subjected to rotations and the resulting structures were energy-minimized. In the lowest energy conformers (energy window 4 kcal/mol) obtained after 500 iterations the respective H-H dis-tances were compared with the NOE data.
• 16. Ahmed M., Atkinson C.E., Barrett A.G.M., Malagu K. and Procopiou P.A., Org. Letters, 5,669 (2003).
• 17. Reischl W., Liebigs Ann. Chem., 587 (1993).
• 18. Simpson R.U., Wichman J.K., Paaren H.E., Schnoes H.K. and DeLuca H.F., Fed. Proc., 41,883 (l 982).
• 19. Verloop A., Koevoet A.L., Van Moorselaar R. and Havinga E., Rec. Trav. Chim. Pays-Bas., 78, 1004 (1959).
• 20. Helmer B., Schnoes H.K. and DeLuca H.F., Arch. Biochem. Biophys., 241, 608 (1985).
• 21. Anet F.A.L., J. Am. Chem. Soc., 84, 1053 (1962).